Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:38 PM
Ignite Modification Date:
2025-12-24 @ 9:38 PM
NCT ID:
NCT05741632
Eligibility Criteria:
Inclusion Criteria:
* Immature senile cataract in one or both eye
* Agree to be included and signed informed consent
Exclusion Criteria:
* Have a history of allergy to moxifloxacin or levofloxacin or any other antibiotics
* Other ocular comorbid such as uveitis, glaucoma, diabetic retinopathy, pseudoexfoliation, and endothelial disorders
* Ocular surgery prior to study
* Sign of infection or inflammation around the eye
* Cataract density more than grade 4 according to Lens Opacities Classification System (LOCS) III grading
* Corneal endothelial cell density \< 1500 cell/ mm2
* Anterior chamber depth \< 2.5 mm
* Diabetes mellitus type 2
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
65 Years
Study:
NCT05741632
Study Brief:
Protocol Section:
NCT05741632